The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn. 2007

Hong Hong, and Jiro Kitaura, and Wenbin Xiao, and Vaclav Horejsi, and Chisei Ra, and Clifford A Lowell, and Yuko Kawakami, and Toshiaki Kawakami
Division of Cell Biology, La Jolla Institute for Allergy and Immunology, CA 92037, USA.

IgE/antigen-dependent mast cell activation plays a central role in immediate hypersensitivity and other allergic reactions. The Src family tyrosine kinase (SFK) Lyn is activated by the cross-linking of high-affinity IgE receptors (FcepsilonRI). Activated Lyn phosphorylates the FcepsilonRI subunits, beta and gamma, leading to subsequent activation of various signaling pathways. Lyn also plays a negative regulatory function by activating negative regulatory molecules. Another SFK, Fyn, also contributes to mast cell degranulation by inducing Gab2-dependent microtubule formation. Here we show that a third SFK, Hck, plays a critical role in mast cell activation. Degranulation and cytokine production are reduced in FcepsilonRI-stimulated hck(-/-) mast cells. The reduced degranulation can be accounted for by defects in Gab2 phosphorylation and microtubule formation. Importantly, Lyn activity is elevated in hck(-/-) cells, leading to increased phosphorylation of several negative regulators. However, positive regulatory events, such as activation of Syk, Btk, JNK, p38, Akt, and NF-kappaB, are substantially reduced in hck(-/-) mast cells. Analysis of lyn(-/-)hck(-/-), lyn(-/-)FcepsilonRIbeta(-/-), and hck(-/-)FcepsilonRIbeta(-/-) cells shows that Hck exerts these functions via both Lyn-dependent and Lyn-independent mechanisms. Thus, this study has revealed a hierarchical regulation among SFK members to fine-tune mast cell activation.

UI MeSH Term Description Entries
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D008870 Microtubules Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS. Microtubule
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D010750 Phosphoproteins Phosphoprotein
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D016147 Genes, Tumor Suppressor Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible. Antioncogenes,Cancer Suppressor Genes,Emerogenes,Genes, Cancer Suppressor,Genes, Growth Suppressor,Genes, Metastasis Suppressor,Growth Suppressor Genes,Metastasis Suppressor Genes,Tumor Suppressor Genes,Anti-Oncogenes,Genes, Onco-Suppressor,Oncogenes, Recessive,Tumor Suppressing Genes,Anti Oncogenes,Anti-Oncogene,Antioncogene,Cancer Suppressor Gene,Emerogene,Gene, Cancer Suppressor,Gene, Growth Suppressor,Gene, Metastasis Suppressor,Gene, Onco-Suppressor,Gene, Tumor Suppressing,Gene, Tumor Suppressor,Genes, Onco Suppressor,Genes, Tumor Suppressing,Growth Suppressor Gene,Metastasis Suppressor Gene,Onco-Suppressor Gene,Onco-Suppressor Genes,Oncogene, Recessive,Recessive Oncogene,Recessive Oncogenes,Suppressor Gene, Cancer,Suppressor Gene, Growth,Suppressor Gene, Metastasis,Suppressor Genes, Cancer,Suppressor Genes, Growth,Suppressor Genes, Metastasis,Tumor Suppressing Gene,Tumor Suppressor Gene

Related Publications

Hong Hong, and Jiro Kitaura, and Wenbin Xiao, and Vaclav Horejsi, and Chisei Ra, and Clifford A Lowell, and Yuko Kawakami, and Toshiaki Kawakami
February 1997, Nature,
Hong Hong, and Jiro Kitaura, and Wenbin Xiao, and Vaclav Horejsi, and Chisei Ra, and Clifford A Lowell, and Yuko Kawakami, and Toshiaki Kawakami
December 2005, The Journal of biological chemistry,
Hong Hong, and Jiro Kitaura, and Wenbin Xiao, and Vaclav Horejsi, and Chisei Ra, and Clifford A Lowell, and Yuko Kawakami, and Toshiaki Kawakami
February 2022, International immunopharmacology,
Hong Hong, and Jiro Kitaura, and Wenbin Xiao, and Vaclav Horejsi, and Chisei Ra, and Clifford A Lowell, and Yuko Kawakami, and Toshiaki Kawakami
November 2002, The Journal of biological chemistry,
Hong Hong, and Jiro Kitaura, and Wenbin Xiao, and Vaclav Horejsi, and Chisei Ra, and Clifford A Lowell, and Yuko Kawakami, and Toshiaki Kawakami
January 2004, Journal of leukocyte biology,
Hong Hong, and Jiro Kitaura, and Wenbin Xiao, and Vaclav Horejsi, and Chisei Ra, and Clifford A Lowell, and Yuko Kawakami, and Toshiaki Kawakami
July 2013, Molecular cancer,
Hong Hong, and Jiro Kitaura, and Wenbin Xiao, and Vaclav Horejsi, and Chisei Ra, and Clifford A Lowell, and Yuko Kawakami, and Toshiaki Kawakami
February 1997, Nature,
Hong Hong, and Jiro Kitaura, and Wenbin Xiao, and Vaclav Horejsi, and Chisei Ra, and Clifford A Lowell, and Yuko Kawakami, and Toshiaki Kawakami
October 2021, Endocrinology,
Hong Hong, and Jiro Kitaura, and Wenbin Xiao, and Vaclav Horejsi, and Chisei Ra, and Clifford A Lowell, and Yuko Kawakami, and Toshiaki Kawakami
May 2024, bioRxiv : the preprint server for biology,
Hong Hong, and Jiro Kitaura, and Wenbin Xiao, and Vaclav Horejsi, and Chisei Ra, and Clifford A Lowell, and Yuko Kawakami, and Toshiaki Kawakami
May 1997, The Journal of experimental medicine,
Copied contents to your clipboard!